AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 207295
Drug: salbutamol infusion
RxNorm normalized name: salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: salbutamol infusion (0.15 microgram kg‐1 min‐1 for 60 min)
Trial: 207295
Drug: propranolol injection
RxNorm normalized name: propranolol Injection
DrugBank: Propranolol (DB00571)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: propranolol injection (0.3 mg kg‐1 for 10 min); salbutamol infusion
Trial: 15704485
Drug: Cerebrolysin 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cerebrolysin 10 ml
Trial: 3147423
Drug: EMLA cream
RxNorm normalized name: LIDOCAINE 25 mg in 1 g / PRILOCAINE 25 mg in 1 g TOPICAL CREAM [Emla Cream]
DrugBank: Prilocaine (DB00750)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: EMLA cream (local anaesthetic)
Trial: 9114771
Drug: Aspirin or
RxNorm normalized name: aspirin Oral Film
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin or Ticlopidine (Control)
Trial: 3552176
Drug: Cephalothin prophylaxis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cephalothin prophylaxis (25 mg/kg, four doses)
Trial: 21992502
Drug: Exercise therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise therapy in addition to GP care
Trial: 18492523
Drug: Metformin adherence
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin adherence with lifestyle change
Trial: 9408812
Drug: Methylphenidate (5
RxNorm normalized name: methylphenidate (50/50 release) 20 mg/24 hr oral capsule, extended release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylphenidate (5 mg plus 20 mg sustained release)
Trial: 17947611
Drug: Clarithromycin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clarithromycin (500 mg twice daily)
Trial: 2874782
Drug: Intracapsular extraction
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracapsular extraction plus Federov implant (Group B)
Trial: 12070950
Drug: Oral fluid
RxNorm normalized name: cascara sagrada ORAL FLUID EXTRACT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral fluid restriction at 60% of normal maintenance volumes
Trial: 11408131
Drug: Heparin-surface-modified poly(methyl
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin-surface-modified poly(methyl methacrylate) (PMMA) IOL
Trial: 20683336
Drug: Monthly Personal
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Monthly Personal Digital Assistant supported home assessments by PLWAs with clinic appointments every 3 months
Trial: 20683336
Drug: Standard of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard of care monthly clinic visits
Trial: 18460033
Drug: darunavir 400
RxNorm normalized name: darunavir 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: darunavir 400 mg bid plus ketoconazole 200 mg bid
Trial: 18460033
Drug: darunavir/ritonavir 400/100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: darunavir/ritonavir 400/100 mg bid plus ketoconazole 200 mg bid
Trial: 18460033
Drug: ketoconazole 200
RxNorm normalized name: ketoconazole 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ketoconazole 200 mg bid with darunavir/ritonavir
Trial: 15860682
Drug: Added dead
RxNorm normalized name: Stahist AD
DrugBank: Chlorcyclizine (DB08936)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Added dead space (400 ml)
Trial: 15860682
Drug: Added dead
RxNorm normalized name: Stahist AD
DrugBank: Chlorcyclizine (DB08936)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Added dead space (400 ml) and 38% O2
Trial: 12970302
Drug: Sustained release
RxNorm normalized name: Sustained Release Buccal Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sustained release melatonin (1.5 mg)
Trial: 25759400
Drug: Placebo (matched,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (matched, with sham titration)
Trial: 12101381
Drug: Adjunctive stenting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjunctive stenting following thrombolytic therapy
Trial: 9523907
Drug: Sucrose solution
RxNorm normalized name: TootSweet 24% Oral Sucrose Solution
DrugBank: Sucrose (DB02772)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sucrose solution (100% energy carbohydrate)
Trial: 7897784
Drug: 3-day treatment
RxNorm normalized name: Gyne-Lotrimin 2% 3-Day Treatment Vaginal Cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3-day treatment with trimethoprim/sulfamethoxazole (TMP/SMX) - one tablet twice daily for 3 days followed by 7 days of placebo
Trial: 7897784
Drug: 10-day treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10-day treatment with trimethoprim/sulfamethoxazole (TMP/SMX) - one tablet twice daily for 10 days
Trial: 23941163
Drug: Clinical equipoise
RxNorm normalized name: DuoCare Clinical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clinical equipoise regarding oral anticoagulation
Trial: 16939067
Drug: EC-MPS (720
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EC-MPS (720 mg b.i.d.)
Trial: 11042570
Drug: Surgery followed
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Surgery followed by one course of perioperative chemotherapy
Trial: 9194107
Drug: Oral ciprofloxacin
RxNorm normalized name: Ciprofloxacin
DrugBank: Ciprofloxacin (DB00537)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral ciprofloxacin (15 mg/kg twice daily; maximum dosage 750 mg twice daily)
Trial: 9194107
Drug: Intravenous ceftazidime
RxNorm normalized name: Ceftazidime
DrugBank: Ceftazidime (DB00438)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous ceftazidime plus tobramycin (CAZ/TM) for 14 days
Trial: 1355971
Drug: Clarithromycin 500
RxNorm normalized name: clarithromycin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clarithromycin 500 mg orally every 12h for 13 doses and intravenous placebo every 8h (n = 5)
Trial: 3030039
Drug: Beta 1-selective
RxNorm normalized name: interleukin-1, beta
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta 1-selective metoprolol (50 mg b.i.d.)
Trial: 3030039
Drug: Non-selective propranolol
RxNorm normalized name: Beta blocking agents, non-selective
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-selective propranolol (40 mg b.i.d.)
Trial: 31447126
Drug: NTHi vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NTHi vaccine
Trial: 21942620
Drug: Oral PHT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral PHT (combined 17β‐estradiol plus norethisterone)
Trial: 21942620
Drug: Oral PHT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral PHT
Trial: 21942620
Drug: Nasal PHT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nasal PHT vs Oral PHT
Trial: 31533663
Drug: Probiotic capsules
RxNorm normalized name: Quad-Probiotic Capsules
DrugBank: Bifidobacterium longum (DB19248)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic capsules (Lactobacillus rhamnosus DSM 14870 and Lactobacillus gasseri DSM 14869) self-administered vaginally once daily for 30 days, then once a week until Day 190.
Trial: 31533663
Drug: Probiotic capsules
RxNorm normalized name: Quad-Probiotic Capsules
DrugBank: Bifidobacterium longum (DB19248)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic capsules self-administered vaginally after antibiotic treatment in Group 2.
Trial: 31533663
Drug: Triple oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple oral antibiotic combination (cefixime 400 mg stat, doxycycline 100 mg BD for 7 days, metronidazole 2 g stat) in Group 2.
Trial: 27449969
Drug: Intrauterine injection
RxNorm normalized name: ETHIODIZED OIL 480 mg in 1 mL INTRAUTERINE INJECTION [LIPIODOL]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrauterine injection of 1000 IU of hCG before embryo transfer (ET) (n=62)
Trial: 27449969
Drug: Placebo group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo group receiving an intrauterine injection of physiological saline before ET (n=49)
Trial: 27449969
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group with no intrauterine injection (n=50)
Trial: 19878123
Drug: β-blockers (control)
RxNorm normalized name: capsaicin
DrugBank: Capsaicin (DB06774)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: β-blockers (control)
Trial: 19165383
Drug: Calcium supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium supplementation (1,200 mg)
Trial: 11502639
Drug: Oral montelukast,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral montelukast, 10 mg qd
Trial: 11502639
Drug: Inhaled salmeterol
RxNorm normalized name: salmeterol Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled salmeterol xinafoate powder, 50 microg bid
Trial: 9249084
Drug: AGG group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AGG group (AG + 110 g glucose)
Trial: 9249084
Drug: AGF group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AGF group (AG + 40 g fat)
Trial: 8500237
Drug: Hydralazine (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydralazine (300 mg daily) plus Isosorbide dinitrate (160 mg daily)
Trial: 3067246
Drug: Femoxetine (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Femoxetine (600 mg recommended daily dosage, flexible dosing)
Trial: 3067246
Drug: Imipramine (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imipramine (150 mg recommended daily dosage, flexible dosing)
Trial: 31844967
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg hesperidin, twice daily for 12 weeks
Trial: 30106248
Drug: D-cycloserine (DCS)
RxNorm normalized name: D-Cycloserine
DrugBank: Cycloserine (DB00260)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: D-cycloserine (DCS) combined with one-session treatment (OST)
Trial: 30106248
Drug: Placebo (PBO)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (PBO) combined with one-session treatment (OST)
Trial: 22784013
Drug: naltrexone 50
RxNorm normalized name: naltrexone 50 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: naltrexone 50 mg
Trial: 16394687
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups at predicted propofol concentration of 3 microg/ml
Trial: 16394687
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups at predicted propofol concentrations of 3 to 7 microg/ml
Trial: 3567002
Drug: Leicester Micropalliator
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Leicester Micropalliator (1 mg h-1 mandatory background infusion + 2 mg i.v. on-demand bolus doses of morphine)
Trial: 3567002
Drug: Cardiff Palliator
RxNorm normalized name: alligator juniper wood oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cardiff Palliator (only 2 mg i.v. on-demand bolus doses of morphine)
Trial: 30993537
Drug: 10% lidocaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10% lidocaine (group L)
Trial: 27476818
Drug: Corticosteroids (prednisolone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroids (prednisolone 15 mg/day)
Trial: 23418430
Drug: Hormone replacement
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormone replacement therapy (HT) regimen discontinued for approximately 2 years (Mean = 1.93 years)
Trial: 17223424
Drug: Cardiac resynchronization
RxNorm normalized name: Leonurus cardiaca extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cardiac resynchronization therapy (CRT) alone
Trial: 9385472
Drug: Alpha 1-blockade
RxNorm normalized name: alpha 1-antitrypsin
DrugBank: Alpha-1-proteinase inhibitor (DB00058)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alpha 1-blockade (5 mg prazosin in preceding 24 h)
Trial: 3322532
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose aspirin (324 mg)
Trial: 21942262
Drug: varenicline (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: varenicline (2 mg/day)
Trial: 26704020
Drug: Azithromycin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azithromycin (10 mg/kg per day for 3 days)
Trial: 12560149
Drug: Cefaclor (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefaclor (40 mg/kg per day for 10 days)
Trial: 3926254
Drug: 30% fat
RxNorm normalized name: Intralipid 30% Fat Emulsion for Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30% fat parenteral diet
Trial: 3926254
Drug: 0% fat
RxNorm normalized name: Blended spread - 40% fat
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0% fat parenteral diet
Trial: 3926254
Drug: 50% fat
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50% fat parenteral diet
Trial: 24658367
Drug: Client-centred therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Client-centred therapy
Trial: 18341600
Drug: 0.02% CHX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.02% CHX solution
Trial: 15817862
Drug: High-sodium diet
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-sodium diet (3.86 g/d sodium)
Trial: 15817862
Drug: Low-sodium diet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-sodium diet (1.30 g/d sodium)
Trial: 16881381
Drug: Reservoir patch
RxNorm normalized name: RESERVOIR,CADD
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reservoir patch
Trial: 11065040
Drug: Transdermal patches
RxNorm normalized name: MENTHOL 0.3 g in 100 TOPICAL PATCH [Aroamas Cot Nicotine Transdermal Patches]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal patches
Trial: 11065040
Drug: Transdermal treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal treatment
Trial: 31679521
Drug: Prolotherapy (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prolotherapy (4 sessions, monthly intervals)
Trial: 31679521
Drug: Physiotherapy (weekly
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physiotherapy (weekly for 4 sessions)
Trial: 27220527
Drug: Manual Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manual Therapy + Kinesio Taping + Exercise (MT + KT + EX)
Trial: 27220527
Drug: High-Intensity Laser
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-Intensity Laser Therapy + Manual Therapy + Kinesio Taping + Exercise (HILT + MT + KT + EX)
Trial: 24554030
Drug: StomaphyX treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: StomaphyX treatment
Trial: 22179130
Drug: Pinitol (1,200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pinitol (1,200 mg)
Trial: 20483969
Drug: Supportive therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supportive therapy and education (Control)
Trial: 11526558
Drug: Morphine mixed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine mixed with bupivacaine
Trial: 11526558
Drug: Control (Sterile
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (Sterile saline solution)
Trial: 24140390
Drug: Bivalent killed
RxNorm normalized name: Hongo Killer
DrugBank: Undecylenic acid (DB11117)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bivalent killed whole-cell oral cholera vaccine (two doses, 14 days apart)
Trial: 19030772
Drug: Insulin glargine
RxNorm normalized name: Insulin Glargine
DrugBank: Insulin glargine (DB00047)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin glargine (at dinnertime)
Trial: 19030772
Drug: Neutral protamine
RxNorm normalized name: Neutral protamine hagedorn insulin
DrugBank: Neutral Protamine Hagedorn (NPH) insulin (DB18001)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neutral protamine Hagedorn (NPH) insulin (at bedtime)
Trial: 9118711
Drug: Inhaled cocaine
RxNorm normalized name: Cocaine
DrugBank: Cocaine (DB00907)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled cocaine base (45 mg)
Trial: 9118711
Drug: IV cocaine
RxNorm normalized name: Cocaine
DrugBank: Cocaine (DB00907)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV cocaine HCl (0.35 to 0.50 mg/kg)
Trial: 9118711
Drug: Inhaled placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled placebo (4.5 mg cocaine base)
Trial: 9118711
Drug: IV placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV placebo (saline solution)
Trial: 9118711
Drug: Cocaine (inhaled
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cocaine (inhaled or IV)
Trial: 7505979
Drug: Serum PSA
RxNorm normalized name: Serum, horse
DrugBank: Serum, horse (DB14613)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serum PSA value of 10 ng/mL or less
Trial: 2941208
Drug: Intravenous infusion
RxNorm normalized name: intravenous infusion pump accessory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous infusion of sodium chloride/potassium chloride solution (saline) 12 ml/kg body weight
Trial: 2941208
Drug: Intravenous infusion
RxNorm normalized name: intravenous infusion pump accessory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous infusion of sodium chloride/potassium chloride solution (saline) 18 ml/kg body weight
Trial: 20035818
Drug: Silybum marianum
RxNorm normalized name: Silybum marianum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Silybum marianum extract (600 mg/day)
Trial: 20035818
Drug: Fluoxetine (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine (30 mg/day)
Trial: 18810506
Drug: Adenosine 5′-triphosphate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adenosine 5′-triphosphate (ATP) infusions, maximum of eight weekly intravenous 8-10 h infusions
Trial: 16407509
Drug: Aerosol cyclosporine
RxNorm normalized name: Cyclosporine
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aerosol cyclosporine (300 mg, three days a week for two years)
Trial: 3327362
Drug: Propranolol plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol plus atropine (0.2 mg kg‐1 plus 0.04 mg kg‐1)
Trial: 16517329
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg of 3% chloroprocaine
Trial: 6475561
Drug: Meglumine, Na‐Ca‐metrizoate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meglumine, Na‐Ca‐metrizoate 370 mg I/ml (Isopaque Coronar)
Trial: 30468530
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose UVA1 (130 J/cm2)
Trial: 29424239
Drug: GLP-1 receptor
RxNorm normalized name: GLP-1 receptor agonist
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GLP-1 receptor agonists (semaglutide)
Trial: 12530280
Drug: Zinc sulphate
RxNorm normalized name: Zinc sulphate
DrugBank: Zinc acetate (DB14487)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Zinc sulphate (single oral dose)
Trial: 9800052
Drug: Diltiazem CR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diltiazem CR (90-120 mg) twice daily
Trial: 8849215
Drug: Azithromycin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azithromycin (10 mg/kg once daily for 3 days)
Trial: 7008293
Drug: Adjunctive antithymocyte
RxNorm normalized name: antithymocyte immunoglobulin (rabbit)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjunctive antithymocyte globulin (ATG) therapy
Trial: 7022879
Drug: Standard antirejection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard antirejection treatment (SAT) of steroid pulsing and local irradiation
Trial: 25546369
Drug: Oral solution
RxNorm normalized name: Oral Solution
DrugBank: Sodium citrate (DB09154)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral solution fasting (50mg)
Trial: 25546369
Drug: Tablet fasting
RxNorm normalized name: Fast Freeze
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tablet fasting (50mg)
Trial: 25546369
Drug: Oral solution
RxNorm normalized name: Oral Solution
DrugBank: Sodium citrate (DB09154)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral solution fed (50mg)
Trial: 25546369
Drug: Tablet fed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tablet fed (50mg)
Trial: 16267767
Drug: Praziquantel treatment
RxNorm normalized name: Praziquantel
DrugBank: Praziquantel (DB01058)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Praziquantel treatment (early treatment group, n=64)
Trial: 16267767
Drug: Delayed treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed treatment (n=66)
Trial: 8543715
Drug: EMDR treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EMDR treatment (3 sessions of 90 minutes each)
Trial: 2102432
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg Ibuprofen administered directly postoperatively (2nd administration after 6 hours)
Trial: 2102432
Drug: Ibuprofen taken
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ibuprofen taken as required
Trial: 25833980
Drug: Lipid-based nutrient
RxNorm normalized name: guggul lipids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lipid-based nutrient supplement (LNS) 20 g/d
Trial: 21946544
Drug: Primary open-angle
RxNorm normalized name: Bos taurus ankle joint preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Primary open-angle glaucoma group with ET-1 level of 3.27±1.25 pg/mL
Trial: 21946544
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group with ET-1 level of 1.53±1.49 pg/mL
Trial: 22315765
Drug: Ketamine 6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine 6 mg kg(‐1)